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Postsystolic Shortening by Speckle Tracking Echocardiography Is an
Independent Predictor of Cardiovascular Events and Mortality in the
General Population
Philip Brainin, MD; Soﬁe Reumert Biering-Sørensen, BVSc; Rasmus Møgelvang, MD, PhD; Peter Søgaard, MD, DMSc; Jan Skov Jensen, MD,
PhD, DMSc; Tor Biering-Sørensen, MD, PhD
Background-—Postsystolic shortening (PSS) has been proposed as a novel marker of contractile dysfunction in the myocardium.
Our objective was to assess the prognostic potential of PSS on cardiovascular events and death in the general population.
Methods and Results-—The study design consisted of a prospective cohort study of 1296 low-risk participants from the general
population, who were examined by speckle tracking echocardiography. The primary end point was the composite of heart failure,
myocardial infarction, and cardiovascular death, deﬁned as major adverse cardiovascular events (MACEs). The secondary end point
was all-cause death. The postsystolic index (PSI) was deﬁned as follows: [(maximum strain in cardiac cyclepeak systolic strain)/
(maximum strain in cardiac cycle)]9100. PSS was regarded as present if PSI >20%. During a median follow-up of 11 years, 149
participants (12%) were diagnosed as having MACEs and 236 participants (18%) died. Increasing number of walls with PSS
predicted both end points, an association that persisted after adjustment for age, sex, estimated glomerular ﬁltration rate, global
longitudinal strain, hypertension, heart rate, left ventricular ejection fraction, LV mass index, pro-B-type natriuretic peptide,
previous ischemic heart disease, systolic blood pressure, average peak early diastolic longitudinal mitral annular velocity (e0), ratio
between peak transmitral early and late diastolic inﬂow velocity (E/A), and left atrial volume index: MACEs (hazard ratio, 1.35; 95%
conﬁdence interval, 1.09–1.67; P=0.006 per 1 increase in walls displaying PSS) and death (hazard ratio, 1.30; 95% conﬁdence
interval, 1.08–1.57; P=0.006 per 1 increase in walls displaying PSS). The strongest predictor of end points was ≥2 walls exhibiting
PSS. The PSI also predicted increased risk of the end points, and the associations remained signiﬁcant in multivariable models:
MACEs (per 1% increase in PSI: hazard ratio, 1.18; 95% conﬁdence interval, 1.02–1.36; P=0.024) and death (per 1% increase in PSI:
hazard ratio, 1.18; 95% conﬁdence interval, 1.05–1.33; P=0.005).
Conclusions-—Presence of PSS in the general population provides independent and long-term prognostic information on the
occurrence of MACEs and death. ( J Am Heart Assoc. 2018;7:e008367. DOI: 10.1161/JAHA.117.008367.)
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C ardiac health continues to be a global burden, and riskstratiﬁcation of patients with early stages of cardiovas-
cular disease is of increasing importance.1 To address this
issue, new echocardiographic modalities, like speckle tracking
echocardiography (STE), have emerged in recent years.
Quantitative assessment of longitudinal deformation mea-
sures and myocardial velocity have allowed identiﬁcation of
even subtle changes in the contractile function, such as
postsystolic shortening (PSS). PSS is deﬁned as late systolic
shortening appearing after aortic valve closure (AVC), and it
occurs in both healthy individuals and in patients experienc-
ing cardiovascular disease.2–4 Assessment of PSS has been
reported useful for detection of acute ischemia and superior
to traditional parameters, such as peak systolic strain and
wall thickening.3,5–7 In the setting of acute ischemia, PSS
represents regional contractile dysfunction. An experimental
study by Asanuma et al8 showed that PSS persisted after
brief periods of ischemia, reﬂecting a state of systolic
stunning that could be used to detect ischemic memory. In
addition, PSS has been evaluated in clinical studies,
suggesting it as a marker of systolic recovery after an
ischemic event.9,10 Although PSS has been reported to be
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present in approximately one third of all myocardial
segments in healthy individuals,4 the signiﬁcance and
prognostic value of PSS in the general population remains
unexplored (Figure 1). It is the aim of this study to
investigate the prognostic potential of PSS on occurrence
of major adverse cardiovascular events (MACEs) and death in
low-risk individuals.
Methods
Patients and Health Examination
This study included all patients examined in the 4th Copen-
hagen City Heart Study from January 2001 to December
2003, who had a detailed echocardiographic examination
performed. The Copenhagen City Heart Study is a longitudinal
cohort study on participants from Copenhagen, Denmark, that
assesses cardiovascular diseases, risk factors, and health
behavior. Participants were prospectively enrolled in the
present study. If a participant underwent an echocardio-
graphic health examination, this was independent of the
participant’s current health status and risk factors. The study
protocol was approved by the local scientiﬁc committee and
complied with the 2nd Declaration of Helsinki. All participants
gave written informed consent before examination. Partici-
pants with prevalent heart failure (International Classiﬁcation
of Diseases, Tenth Revision [ICD-10] code I50) or atrial
ﬁbrillation diagnosed by ECG or during the echocardiographic
examination were excluded. Measurements of PSS by STE
were available for 1296 participants.
As a part of the physical health examination, all partic-
ipants answered a self-administered questionnaire. Blood
pressure was examined with a sphygmomanometer, and
nonfasting venous blood samples were used for measurement
of cholesterol and blood glucose. Quantiﬁcation of plasma
pro-B-type natriuretic peptide was determined in an assay-
independent method, and deﬁnitions of hypertension, dia-
betes mellitus, and previous ischemic heart disease have been
described in detail previously.11–15 Because of the sensitive
nature of the data collected for this study, requests to access
the data set should be sent to the Danish Ministry of Health,
the Danish Data Protection Agency, the Steering Committee
of the Copenhagen City Heart Study, and the corresponding
author.
Echocardiography
Echocardiography was performed with a Vivid 5 ultrasound
system (GE Healthcare, Horten, Norway) using a 2.5-MHz
transducer. Assessment of conventional 2-dimensional
echocardiography and tissue Doppler imaging was performed
by trained and experienced sonographers. All data were
stored on optical disks and on external hard drives (FireWire,
LaCie, France), allowing ofﬂine analysis with echocardio-
graphic software (EchoPac, version 2008; GE Medical,
Horten, Norway). The investigator was blinded to all other
information.
Conventional echocardiography
Conventional echocardiography was performed during resting
conditions, and regional function was evaluated by the 16
standard segments model in accordance with recommenda-
tions from the American Society of Echocardiography.16
Analysis of left ventricular (LV) ejection fraction (LVEF) was
performed by only 1 examiner on the basis of the wall motion
score index. Systolic LV dysfunction was regarded as LVEF
<50%. LV mass index was calculated by dividing LV mass by
body surface area.
Speckle tracking echocardiography
The 2-dimensional STE was attained from the 3 apical
projections: 2-, 3-, and 4-chamber views, with an average of
57 frames per second (SD, 4 frames per second). Six
myocardial walls of interest were examined: the septal,
lateral, anterior, posterior, inferior, and anteroseptal myocar-
dial walls. Each was divided into subsegments according to
the protocol from the American Society of Echocardiography.
In the end systole, an automated function deﬁned a region of
interest (ROI), thus allowing tracing of the endocardial border.
To ensure correct tracking of speckles, the responsible
investigator visually assessed the automatically deﬁned ROI.
When necessary, the ROI was manually redeﬁned by the
investigator. A tracking was regarded as adequate if the
following occurred: (1) it covered all of the myocardial wall,
Clinical Perspective
What Is New?
• This study shows that postsystolic shortening by speckle
tracking echocardiography is a predictor of major adverse
cardiovascular events and death in the general population.
• Postsystolic shortening remained an independent risk
predictor after adjustment for diastolic and systolic
echocardiographic measurements.
What Are the Clinical Implications?
• Presence of postsystolic shortening may be assessed both
categorically and continuously and could lead to changes in
risk stratiﬁcation, therapy, or follow-up.
• Easy identiﬁcation of postsystolic shortening should encour-
age its use for long-term risk assessment in low-risk
individuals.
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(2) it spanned from the endocardium to the myoepicardial
border, and (3) the motion of speckles was visible. If speckles
were inadequately visualized, the ROI was manually read-
justed. Any tracking not satisfying these requirements or
compromised by artefacts/shadows was excluded. When the
ROI was set to cover the entire LV, an average value of peak
strain from all projections was used to determine global
longitudinal strain (GLS). Our laboratory has previously
demonstrated good intraobserver and interobserver agree-
ment for speckle tracking calculations.17 Our laboratory also
found good intraobserver and interobserver variability, with
only a small bias for PSS (mean difference1.96 SDs was
0.20.95 for intraobserver analysis and 0.040.73 for
interobserver analysis) and postsystolic index (PSI; mean
difference1.96 SDs was 0.250.74 for intraobserver anal-
ysis and 0.060.56 for interobserver analysis). Data used to
calculate PSS were extracted from the 18 myocardial
segments. The PSI was derived from the strain curve, as
follows: [(maximum strain in cardiac cyclepeak systolic
strain)/(maximum strain in cardiac cycle)]9100 (Figure 2).
For analysis, the average of PSI from all myocardial walls was
used. PSS was assessed qualitatively and regarded as present
if PSI was >20%. This cutoff value was based on previous
evidence evaluating PSS.4,18 If 1 segment within a myocardial
wall displayed PSS, the wall was categorized as having the
presence of PSS. Postsystolic strain was calculated as the
absolute difference between maximum strain in the cardiac
cycle and systolic strain. Peak postsystolic time was calcu-
lated as the time difference between AVC and peak postsys-
tolic strain (Figure 2). Participants with left and right bundle
branch block (LBBB/RBBB, respectively) were excluded in a
series of sensitivity analyses.
Follow-Up Data
All participants enrolled in the study cohort between 2001
and 2003 were observed until time of event or April 2013.
Outcomes were determined from the Danish National Board
of Health’s National Patient Registry using the ICD-10. Follow-
up was 100% complete. The primary end point was MACEs,
deﬁned as the composite of heart failure, myocardial infarc-
tion, and cardiovascular death. Cardiovascular death was
deﬁned as ICD-10 codes I00 to I99. The secondary end point
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Figure 2. Schematic drawing of measurement of postsystolic
index (PSI). Longitudinal strain proﬁle with postsystolic shortening
(black curve) and normal strain proﬁle (gray curve). PSI was
calculated as follows: [(maximum strain in cardiac cyclesystolic
strain)/(maximum strain in cardiac cycle)]9100. AVC indicates
aortic valve closure.
Figure 1. Example of postsystolic shortening (PSS) by speckle tracking echocardiography. Longitudinal
strain proﬁles in 6 segments of the 4-chamber view, where PSS is present in the apical segment (green curve)
and exceeds 20% of maximal strain during cardiac cycle. AVC indicates aortic valve closure; and SL,
longitudinal strain.
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was death. All follow-up data were collected from the national
Danish Causes of Death Registry.
Statistical Analysis
Baseline clinical data for the population were stratiﬁed
according to number of walls displaying PSS and tertiles of
PSI. Differences between groups for categorical variables
were compared using the v2 test. P value for trend was
calculated using linear regression models and the v2 trend
test. Variables were tested for gaussian distribution using
qqplot. The summarized number of segments displaying PSS
was calculated and accordingly 3 groups were constructed:
(1) no walls with PSS, (2) 1 wall with PSS, and (3) ≥2 walls
with PSS. Univariable and multivariable Cox proportional
hazards models were used to calculate hazard ratios (HRs).
Multivariable Cox proportional hazards models were adjusted
for the clinically relevant confounders: age, sex, hypertension,
heart rate, LV mass index, LVEF (<50%), GLS, pro-B-type
natriuretic peptide, previous ischemic heart disease, systolic
blood pressure, left atrial volume index, e0, and E/A. LVEF was
adjusted for as a dichotomous variable, with cutoff at 50%.
Cumulated event rates were estimated with the Kaplan-Meier
method and compared using the log-rank test. Harrell’s
C-statistics were calculated from univariable Cox proportional
hazards models to investigate the prognostic performance of
PSS for predicting each end point. PSI was converted to a
normal distribution using a logarithmic transformation, and
cubic spline plots were made. P≤0.05 in 2-sided tests were
regarded as statistically signiﬁcant. All analyses were per-
formed using Stata SE, version 13.1 (StataCorp LP, College
Station, TX).
Results
A total of 1323 participants were examined by conventional
echocardiography and STE as part of a general health
examination. Of these participants, 27 were excluded because
of atrial ﬁbrillation or prevalent heart failure. A total of 34
participants (0.03%) had known LBBB or RBBB. Mean age of
the study population (n=1296) was 56.916.2 years, with a
total of 549 men (42.4%). Baseline clinical characteristics are
displayed in Table 1. During a median follow-up of 11.0 years
(interquartile range, 9.9–11.2 years), 149 participants (11.5%)
were diagnosed as having MACEs and 236 participants
(18.1%) died.
The prevalence of PSS in the study population was 35.0%
(n=453), and a total of 591 myocardial wall segments
exhibiting PSS were identiﬁed. Participants with presence of
PSS were, in general, older, had hypertension, had higher
systolic and mean arterial pressures, had lower LVEF and
estimated glomerular ﬁltration rate, had increased LV mass
index and body mass index, and were more frequently treated
with heart medication (Table 1). In addition, they had a higher
incidence of heart failure, cardiovascular death, MACEs, and
death. Increasing numbers of walls with PSS were related to a
lower GLS, such that participants with no PSS had a mean GLS
of 18.43.7%, those with 1 wall of PSS had a mean GLS of
17.53.6%, and those with ≥2 walls of PSS had a mean GLS
of 16.83.4% (P trend <0.001). Time from AVC until peak
PSS increased incrementally with number of walls displaying
PSS. In participants with 1 wall versus those with ≥2 walls
exhibiting PSS, the median peak time was 29.9 ms versus
45.1 ms after AVC. When the population was stratiﬁed in
tertiles according to PSI, postsystolic strain and peak postsys-
tolic time increased throughout each tertile (Table 2). Interest-
ingly, no signiﬁcant difference was found for afterload and GLS
between the ﬁrst and second tertile. Unadjusted HRs (95%
conﬁdence intervals [CIs]) for echocardiographic measures
(GLS, left atrial volume index, and e0) are displayed in Table 3.
Ordinal Analysis
Per 1 increase in number of walls displaying PSS was
associated with a signiﬁcantly increased risk of MACEs and
death (Table 4). In multivariable models, both associations
remained signiﬁcant: MACEs (HR, 1.51; 95% CI, 1.19–1.91;
P=0.001) and death (HR, 1.24; 95% CI, 1.00–1.54; P=0.045).
Exclusion of participants with LBBB and RBBB did not alter the
results: MACEs (HR, 1.34; 95% CI, 1.08–1.67; P=0.009) and
death (HR, 1.31; 95% CI, 1.08–1.59; P=0.006). Participants
were stratiﬁed into 3 groups according to number of walls with
PSS: (1) no PSS (n=843), 1 wall (n=335), and ≥2 walls (n=118).
The risk of MACEs and death increased incrementally with
number of walls displaying PSS (log-rank P<0.001 for both end
points). However, in multivariable models, only presence of PSS
in ≥2 walls remained a signiﬁcant predictor of MACEs (HR,
2.46; 95% CI, 1.48–4.11; P=0.001) and death (HR, 1.69; 95%
CI, 1.06–2.68; P=0.026) (Table 5, Figure 3A and 3B). The
results also remained signiﬁcant when participants with LBBB
and RBBB were excluded: MACEs (HR, 1.88; 95% CI, 1.16–3.06;
P=0.010) and death (HR, 1.83; 95% CI, 1.19–2.79; P=0.005). In
unadjusted models, PSS had higher HRs for both end points
compared with GLS (Table 3). In terms of predictive power for
MACEs (C-statistic for PSS versus GLS: 0.59 versus 0.62;
P=0.243) and death (C-statistic for PSS versus GLS: 0.57
versus 0.56; P=0.554), there were no signiﬁcant differences
between PSS and GLS.
Continuous Analysis
PSI showed a nongaussian distribution, which was success-
fully converted to a gaussian distribution using logarithmic
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Table 1. Baseline Clinical Characteristics Stratiﬁed According to Number of Walls Displaying PSS
Characteristics
Walls with presence of PSS
P Value for TrendNo PSS (n=843) PSS, 1 Wall (n=335) PSS, ≥2 Walls (n=118)
Demographics
Age, y 55.016.4 59.515.7 64.013.0 <0.001
Female sex, n (%) 490 (58.1) 191 (57.0) 66 (55.9) 0.72
Clinical characteristics
Hypertension, n (%) 282 (33.6) 144 (43.1) 63 (53.4) <0.001
Mean arterial pressure,
mm Hg
9413 9813 10317 <0.001
Diabetes mellitus, n (%) 74 (8.8) 34 (10.3) 14 (11.9) 0.23
Systolic blood pressure, mm Hg 13122 13722 14325 <0.001
Dyslipidemia, n (%) 107 (14.1) 61 (19.9) 18 (16.2) 0.10
BMI, kg/m2 24.83.4 25.63.9 25.03.3 0.021
eGFR, mL/min per 1.73m2 77.515.9 73.815.1 73.815.5 <0.001
Smoking, n (%)
Previous 262 (34.6) 94 (30.7) 38 (33.9) 0.47
Current 251 (32.7) 112 (35.9) 38 (33.9) 0.61
Never 244 (32.2) 100 (32.7) 36 (32.1) 1.00
Heart rate, bpm 6510 6711 6712 <0.001
Heart medication, n (%) 57 (6.8) 42 (12.6) 16 (13.6) 0.001
Pro-BNP, pmol/L 21.522.9 22.423.6 29.232.6 0.007
Previous ischemic heart
disease, n (%)
35 (4.2) 19 (5.7) 10 (8.5) 0.043
Echocardiographic characteristics
PSI, % 1.23.0 8.22.2 14.92.0 <0.001
Postsystolic strain, % 4.73.6 18.513.4 22.510.4 <0.001
Peak postsystolic time, ms 21.1 (10.1–39.4) 29.9 (15.8–49.5) 45.1 (27.9–64.5) <0.001
GLS, % 18.43.7 17.53.6 16.83.4 <0.001
LVEF, % 59.91.1 59.81.5 59.13.9 <0.001
LVMI, g/m2 80 (69–94) 84 (72–99) 89 (76–107) <0.001
LAD, cm 3.40.4 3.40.4 3.50.4 <0.001
Left atrial volume index, mL/m2 19.35.8 19.76.3 22.17.3 <0.001
e0 7.92.7 6.82.4 6.22.4 <0.001
E/e0 9.3 (7.7–11.7) 10.3 (8.3–13.3) 10.5 (8.5–14.1) <0.001
E/A 1.1 (0.9–1.4) 1.0 (0.8–1.2) 0.9 (0.8–1.1) <0.001
Event, n (%)
Heart failure 44 (5.2) 19 (5.7) 15 (12.7) 0.009
Myocardial infarction 23 (2.7) 14 (4.2) 6 (5.1) 0.094
Cardiovascular death 33 (3.9) 25 (7.5) 16 (13.6) <0.001
MACEs 75 (8.9) 43 (12.9) 31 (26.3) <0.001
Death 128 (15.2) 65 (19.4) 43 (36.4) <0.001
Data are given as meanSD or median (interquartile range), unless otherwise indicated. BMI indicates body mass index; BNP, B-type natriuretic peptide; bpm, beats per minute; e0 , average
peak early diastolic longitudinal mitral annular velocity; E/A, ratio between peak transmitral early and late diastolic inﬂow velocity; E/e’, ratio between peak transmitral early diastolic inﬂow
velocity and peak early diastolic longitudinal mitral annular velocity; eGFR, estimated glomerular ﬁltration rate; GLS, global longitudinal strain; LAD, left atrial dimension; LVEF, left
ventricular ejection fraction; LVMI, left ventricular mass index; MACE, major adverse cardiovascular event; PSI, postsystolic index; and PSS, postsystolic shortening.
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Table 2. Baseline Clinical Characteristics Stratiﬁed According to Tertiles of PSI
Characteristics
PSI in Tertiles
P Value for Trend1 (n=432) 2 (n=432) 3 (n=432)
Demographics
Age, y 55.116.7 54.816.1 61.015.0 <0.001
Female sex, n (%) 244 (56.5) 257 (59.5) 246 (56.9) 0.56
Clinical characteristics
Hypertension, n (%) 148 (34.3) 137 (31.9) 204 (47.3) <0.001
Mean arterial pressure,
mm Hg
9413 9413 9914 <0.001
Diabetes mellitus, n (%) 46 (10.6) 30 (7.0) 46 (10.6) 0.99
Systolic blood pressure,
mm Hg
13122 13123 13822 <0.001
Dyslipidemia, n (%) 42 (10.9) 75 (19.0) 69 (17.3) 0.02
BMI, kg/m2 24.63.4 24.83.5 25.53.7 0.001
eGFR, mL/min per 1.73m2 78.116.3 77.415.0 73.215.5 <0.001
Smoking, n (%)
Previous 134 (34.8) 134 (34.3) 126 (31.6) 0.59
Current 127 (32.5) 132 (33.4) 142 (35.1) 0.74
Never 124 (32.2) 125 (32.0) 131 (32.8) 0.96
Heart rate, bpm 6410 6510 6711 0.005
Heart medication, n (%) 25 (5.8) 37 (8.6) 53 (12.3) <0.001
Pro-BNP, pmol/L 22.022.9 20.122.0 25.227.1 0.040
Previous ischemic heart disease, n (%) 13 (3.0) 21 (4.9) 30 (6.9) 0.004
Echocardiographic characteristics
PSI, % 0.42.5 2.51.5 11.02.0 <0.001
Postsystolic strain, % 3.25.6 7.03.8 19.312.8 <0.001
Peak postsystolic time, ms 15.7 (5.4–34.6) 20.6 (11.1–36.6) 39.0 (22.4–60.1) <0.001
GLS, % 18.63.7 18.53.6 17.13.6 <0.001
LVEF, % 59.90.8 59.91.1 59.52.5 <0.001
LVMI, g/m2 79 (69–96) 79 (69–93) 86 (73–101) <0.001
LAD, cm 3.40.3 3.30.4 3.50.4 0.001
Left atrial volume index, mL/m2 19.05.8 19.45.7 20.56.9 0.001
e0 8.02.9 7.92.6 6.62.4 <0.001
E/e0 9.2 (7.6–11.6) 9.4 (7.8–11.7) 10.4 (8.5–13.8) <0.001
E/A 1.1 (0.9–1.5) 1.1 (0.9–1.4) 1.0 (0.8–1.2) <0.001
Event, n (%)
Heart failure 22 (5.1) 21 (4.9) 35 (8.1) 0.006
Myocardial infarction 16 (3.7) 7 (1.6) 20 (4.6) 0.44
Cardiovascular death 15 (3.5) 18 (4.2) 41 (9.5) <0.001
MACEs 40 (9.3) 36 (8.3) 73 (16.9) <0.001
Death 65 (15.0) 58 (13.4) 113 (26.2) <0.001
Data are given as meanSD or median (interquartile range), unless otherwise indicated. BMI indicates body mass index; BNP, B-type natriuretic peptide; bpm, beats per minute; e0 , average
peak early diastolic longitudinal mitral annular velocity; E/A, ratio between peak transmitral early and late diastolic inﬂow velocity; E/e’, ratio between peak transmitral early diastolic
inﬂow velocity and peak early diastolic longitudinal mitral annular velocity; eGFR, estimated glomerular ﬁltration rate; GLS, global longitudinal strain; LAD, left atrial dimension; LVEF, left
ventricular ejection fraction; LVMI, left ventricular mass index; MACE, major adverse cardiovascular event; and PSI, postsystolic index.
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transformation. The incidence of MACEs and death increased
incrementally with increasing PSI. Likewise, increasing PSI
was associated with signiﬁcantly increased risk of both end
points (Figure 4A and 4B). A continuous analysis of PSI
showed that a 1% increase provided prognostic information on
both MACEs and death, and the associations remained
signiﬁcant after multivariable adjustment (Table 4). The
associations remained signiﬁcant when participants with
LBBB and RBBB were excluded: adjusted MACEs (HR, 1.17;
95% CI, 1.01–1.35; P=0.035) and adjusted death (HR, 1.18;
95% CI, 1.05–1.33; P=0.007). Stratiﬁed according to tertiles
of PSI (n=432), participants in the third tertile had a
signiﬁcantly increased risk of MACEs and death (log-rank
P<0.001 for both end points). After adjustment, those in the
third tertile demonstrated a 2-fold increased risk of MACEs
(ﬁrst versus third tertile: HR, 2.18; 95% CI, 1.21–3.91;
P=0.009) and a little lower risk of death (ﬁrst versus third
tertile: HR, 1.78; 95% CI, 1.11–2.84; P=0.017) (Table 5).
Exclusion of participants with LBBB and RBBB had only minor
impact on the previous results: MACEs (ﬁrst versus third
tertile: HR, 1.83; 95% CI, 1.05–3.20; P=0.033) and death (ﬁrst
versus third tertile: HR, 1.90; 95% CI, 1.21–3.00; P=0.005). In
comparison with GLS, the PSI maintained higher HRs in
unadjusted analyses for both end points (Table 3). For
MACEs, the predictive performance was nearly the same (C-
statistic for PSI versus GLS: 0.63 versus 0.62; P=0.739);
however, for death, the PSI had a signiﬁcantly better
performance than GLS (C-statistic for PSI versus GLS: 0.62
versus 0.56; P=0.007).
Discussion
In this prospective study of the general population, we
demonstrated that PSS assessed by STE provides indepen-
dent prognostic information on the occurrence of MACEs and
death. To the best of our knowledge, no study has addressed
the prognostic value of PSS in a low-risk general population.
Previous studies have focused on PSS in the settings of
acute ischemia and chronic coronary artery disease,5,7,8,19,20
Table 3. Unadjusted HRs With 95% CIs for MACEs and Death
Echocardiographic
Measures
Per 1 Increase
MACEs
HR (95% CI) P Value
Death
HR (95% CI) P Value
GLS, % 1.12 (1.08–1.17) <0.001 1.05 (1.02–1.09) 0.004
LAVI, mL/m2 1.07 (1.05–1.10) <0.001 1.06 (1.04–1.08) <0.001
e0 0.63 (0.58–0.69) <0.001 0.67 (0.64–0.72) <0.001
CI indicates conﬁdence interval; e0 , average peak early diastolic longitudinal mitral annular velocity; GLS, global longitudinal strain; HR, hazard ratio; LAVI, left atrial volume index; and
MACE, major adverse cardiovascular event.
Table 4. Risk of MACEs and Death According to Increasing Number of Walls With PSS and Increasing PSI
Variable
MACEs
HR (95% CI) P Value
Death
HR (95% CI) P Value
No. of walls with PSS
Unadjusted
Per 1 increase in number of walls 1.59 (1.34–1.89)
(C-statistic, 0.59)
<0.001 1.51 (1.31–1.75)
(C-statistic, 0.57)
<0.001
Adjusted*
Per 1 increase in number of walls 1.51 (1.19–1.91) 0.001 1.24 (1.00–1.54) 0.045
PSI
Unadjusted
PSI per 1% increase 1.36 (1.20–1.54)
(C-statistic, 0.63)
<0.001 1.33 (1.21–1.47)
(C-statistic, 0.62)
<0.001
Adjusted*
PSI per 1% increase 1.22 (1.04–1.43) 0.014 1.14 (1.00–1.30) 0.044
CI indicates conﬁdence interval; HR, hazard ratio; MACE, major adverse cardiovascular event; PSI, postsystolic index; and PSS, postsystolic shortening.
*Adjusted for sex, age, hypertension, heart rate, left atrial volume index, left ventricular mass index, ejection fraction, global longitudinal strain, pro-B-type natriuretic peptide, previous
ischemic heart disease, systolic blood pressure, average peak early diastolic longitudinal mitral annular velocity (e0), ratio between peak transmitral early and late diastolic inﬂow velocity
(E/A), and estimated glomerular ﬁltration rate.
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where PSS acts as both a marker of ischemic insults and a
predictor of systolic recovery. Because of this, only few
studies have examined the incidence of PSS among healthy
individuals and none have examined the incidence in a low-
risk population. No studies have associated PSS with
outcome. In this study, we found a prevalence of PSS of
35%, a ﬁnding almost similar to that of Voigt et al, who
examined healthy participants and found an incidence of
31%.4 In healthy individuals, physiological PSS is a part of a
natural and balanced reshaping process that occurs during
the isovolumetric relaxation time. In participants experienc-
ing cardiovascular disease, PSS is believed to occur
because of passive elastic recoil caused by heterogeneity
between dyskinetic myocardial segments and healthy
tissue.2,21 We used a 20% cutoff value of PSI, as suggested
by Voigt et al,4 to qualitatively differentiate between
pathological and physiological PSS. Furthermore, we
assessed PSS continuously using the PSI. Both methods
for assessing the prognostic value of PSS were indepen-
dently associated with outcomes.
By examining the general population, we were able to
explore the presence of PSS and outcome at different stages.
In the study cohort, we found that increasing number of walls
displaying PSS and a high PSI were associated with worse
outcome. When PSI was stratiﬁed according to tertiles,
participants in the second tertile of PSS had, albeit modest, a
lower incidence of MACEs and death, a signiﬁcantly greater
postsystolic strain, and longer peak postsystolic time. In the
second tertile, mean PSI was 2.5% and conventional echocar-
diographic measurements (EF, GLS, and LV mass index) were
normal. Hence, echocardiographic measures could not be
used to differentiate participants in the second tertile from
those in the ﬁrst tertile. In comparison, participants in the
third tertile of PSI (mean PSI, 11.0%) had a signiﬁcantly
Table 5. Risk of MACEs and Death According to Grouped Number of Walls With PSS and Tertiles of PSI
Variable
MACEs
HR (95% CI) P Value
Death
HR (95% CI) P Value
No. of walls with PSS
Unadjusted
Per 1 increase in category of walls with PSS 1.76 (1.43–2.17)
(C-statistic, 0.59)
<0.001 1.56 (1.32–1.86)
(C-statistic, 0.57)
<0.001
0 Walls Reference Reference
1 Wall 1.47 (1.01–2.14) 0.044 1.29 (0.96–1.74) 0.094
≥2 Walls 3.31 (2.17–5.03) <0.001 2.68 (1.90–3.79) <0.001
Adjusted*
Per 1 increase in category of walls with PSS 1.54 (1.19–1.99) 0.001 1.24 (0.99–1.55) 0.067
0 Walls Reference Reference
1 Wall 1.32 (0.84–2.11) 0.225 1.02 (0.69–1.50) 0.924
≥2 Walls 2.46 (1.48–4.11) 0.001 1.69 (1.06–2.68) 0.026
Tertiles of PSI
Unadjusted
Per 1 increase in tertiles 1.75 (1.40–2.18)
(C-statistic, 0.62)
<0.001 1.68 (1.40–2.00)
(C-statistic, 0.61)
<0.001
1 Reference Reference
2 1.44 (0.87–2.38) 0.151 1.43 (0.96–2.12) 0.075
3 2.89 (1.84–4.54) <0.001 2.70 (1.88–3.86) <0.001
Adjusted*
Per 1 increase in tertiles 1.51 (1.13–2.02) 0.006 1.36 (1.07–1.72) 0.011
1 Reference Reference
2 1.27 (0.69–2.33) 0.437 1.14 (0.70–1.87) 0.588
3 2.18 (1.21–3.91) 0.009 1.78 (1.11–2.84) 0.017
CI indicates conﬁdence interval; HR, hazard ratio; MACE, major adverse cardiovascular event; PSI, postsystolic index; and PSS, postsystolic shortening.
*Adjusted for sex, age, hypertension, heart rate, left atrial volume index, left ventricular mass index, ejection fraction, global longitudinal strain, pro-B-type natriuretic peptide, previous
ischemic heart disease, systolic blood pressure, average peak early diastolic longitudinal mitral annular velocity (e0), ratio between peak transmitral early and late diastolic inﬂow velocity
(E/A), and estimated glomerular ﬁltration rate.
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increased incidence of events and a lower survival rate.
Previous studies support the hypothesis that PSS is a
dichotomous phenomenon that either represents cardiac
viability or regional contractility defects.4,20,22 In contrast to
this, our ﬁndings suggest that occurrence of PSS should not
solely be regarded dichotomous. Instead, it should be
regarded as a dynamic and progressive phenomenon that
may alter over time in low-risk individuals and, thus, develop
from a physiological to a pathological state. We hypothesize
when PSS occurs at a low magnitude and with increased
postsystolic time it represents active myocardial ﬁbers;
however, when PSS gradually develops and exceeds 11% of
maximum strain in the cardiac cycle, it’s presence is
pathologic and associated with increased risk of MACEs and
death. Several conditions should be taken into account
considering our ﬁndings. First, a relative difference exists
between the current population and previous studies as they
did the following: (1) examined patients experiencing known
or suspected ischemic heart disease4,7,20,22–25 or (2) per-
formed animal experiments.3,26,27 Second, we only assessed
longitudinal deformation measurements and not radial thick-
ening, which might have inﬂuenced our results.
PSS is a phenomenon that occurs widely in the general
population, and differentiation between physiological and
pathological PSS is of crucial importance for its use in clinical
settings. To fully explore the prognostic potential of PSS in
low-risk individuals, a more detailed understanding of the
mechanisms causing progression of PSS is needed, thus
allowing us, with greater detail, to determine if PSS is derived
from viable or dysfunctional myocardial segments. We found
that participants with increasing number of walls with PSS
had signiﬁcantly more comorbidity, were older, and had lower
Figure 3. A and B, Kaplan-Meier survival curves with patients
stratiﬁed according to number of walls displaying postsystolic
shortening (PSS): no walls, 1 wall, and ≥2 walls. A, Participants
with PSS in ≥2 walls had the highest risk of major adverse
cardiovascular events (MACEs) (hazard ratio [HR], 3.31; 95%
conﬁdence interval [CI], 2.17–5.03). B, Participants with PSS in
≥2 walls had the highest risk of death (HR, 2.68; 95% CI, 1.90–
3.79).
Figure 4. A and B, Cubic spline plots of postsystolic index (PSI).
Association between log(PSI) and risk of major adverse cardio-
vascular events (MACEs) and death in the population. Black and
blue lines show unadjusted hazard ratio (HR) with 95% conﬁdence
interval for increasing values of ln(PSI). Orange line is HR of 1.0.
The histogram shows the distribution of PSI. Increasing ln(PSI) is
associated with increased risk of MACEs (A) and increased risk of
death (B).
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GLS; peak PSS also occurred later in the cardiac cycle in
these participants. Because PSS was highly related with both
age and comorbidity, this might reduce its predictive value in
a low-risk general population because both PSS and comor-
bidities are linked to cardiovascular events and mortality. Yet,
our results demonstrate that PSS remains an independent
predictor of both MACEs and death after adjustment for all
the aforementioned comorbidities, and the fact that it is easily
accessible by STE should add to the identiﬁcation of this
phenomenon in clinical settings.
Strengths and Limitations
The study population is from the Copenhagen City Heart
Study, a large community-based cohort involving a homoge-
neous sample of men and women across different ages with
complete follow-up. This is a major strength to the current
study. Using STE for assessment was an advantage compared
with studies using tissue Doppler imaging,9 because this
method reduced any user-dependent estimation of PSS and is
regarded as a more reliable technique for quantifying
deformation measurements. However, speckle tracking is a
noninvasive technique for assessment of myocardial wall
forces; thus, it cannot distinguish active from passive forces
or reveal the true cause of myocardial deformation. Bundle
branch block is known to be a contributor to occurrence of
PSS, explaining why we performed series of sensitivity
analyses excluding participants with known LBBB/RBBB.
Skulstad et al27 showed that increasing LV peak systolic
and end-diastolic pressures was related to higher occurrence
of PSS. To reduce the inﬂuence of loading conditions on the
prognostic value of PSS, we adjusted for systolic blood
pressure and hypertension in our multivariable models.
A limitation to the current study is that we examined the
magnitude and peak time of PSS, but we did not assess the
total duration of PSS after AVC, the isovolumetric relaxation
time. This might have provided additional information on the
physiological features of PSS. Data on radial and circumfer-
ential deformational measurements were not available,
allowing us to only examine longitudinal deformation. Infor-
mation on these measurements may have added to a greater
understanding of the physiological features of PSS. Data on
changes in treatment or cardiac interventions during the
follow-up were not available. Thus, effect of treatment may
have inﬂuenced the presence of PSS over time and its
association with events. A recent guideline for standardization
of deformation imaging highlighted the variability in regional
strain measurements.28 To reduce this variability, we
regarded PSS as a global phenomenon. Hence, we assessed
the summarized number of walls displaying PSS from all
regions, and PSI was calculated as the mean from all
myocardial regions. In performing speckle analyses, the width
of the ROI may have inﬂuenced occurrence of PSS. We did not
keep track of how often the ROI was manually adjusted, nor
did we examine the impact of ROI width on PSS.
Conclusion
PSS assessed by STE in a low-risk general population provides
novel and independent long-term prognostic information on
the risk of MACEs and death. Albeit PSS is associated with
increasing comorbidity and age, the easy identiﬁcation of PSS
by STE should encourage its use for long-term risk assess-
ment in individuals with low risk of cardiovascular disease.
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